<a href="https://laohu8.com/S/SGRY">Surgery Partners</a> Reports Third Quarter Revenue Up 6.6%
Surgery Partners Inc. reported third quarter 2025 revenue of $716.7 million, a 6.6% increase compared to the prior year period. Same-facility revenues rose by 6.3%. Surgical cases grew by 2.1%, with same-facility cases increasing 3.4%. The company reported a net loss attributable to Surgery Partners Inc. of $22.7 million for the quarter. Adjusted EBITDA increased 6.1% to $136.4 million. As of September 30, 2025, the company held $203.4 million in cash and cash equivalents, with $405.9 million available under its revolving credit facility. Cash flows from operating activities were $83.6 million for the third quarter, up from $65.2 million in the same period of 2024. Year-to-date operating cash flows totaled $170.9 million, compared to $188.7 million in the prior year period. For full year 2025, Surgery Partners expects revenue of $3.28 billion to $3.30 billion and Adjusted EBITDA of $535 million to $540 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Surgery Partners Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001638833-25-000159), on November 10, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.